A new way to reprogram immune cells and direct them toward anti-tumor immunity
Posted:
An interdisciplinary group of researchers has revealed a new strategy for helping the immune system fight against cancer cells. Their discovery causes a potent immune response and could be used to develop a potential tumor vaccine. Read the full article in the MIT School of Engineering blog post here.
Waystar has signed a definitive agreement to acquire Iodine Software, a $1.25 billion deal that seeks to empower healthcare payments with more AI capabilities.
Read more here.
Doctors will be able to prescribe a new treatment for people with inflammatory bowel disease (IBD), after the UK medicines watchdog approved guselkumab (Tremfya) for use on the NHS.
Read more here.
Attendees
Sponsors and Exhibitors
Contact us